The Impact of Clomiphene Citrate-Metformin Combination Versus Clomiphene Citrate Monotherapy on Ovulation in Infertile Patients with Average BMI
DOI:
https://doi.org/10.70749/ijbr.v3i7.2018Keywords:
Clomiphene citrate, Metformin, Ovulation induction, Infertility, Insulin-sensitizing agents, BMIAbstract
Background: Ovulation induction represents one of the most important treatments for infertility and most commonly utilizes clomiphene citrate. Nevertheless, evidence from recent studies indicates that the addition of metformin may enhance treatment success in women of normal BMI. Objective: To compare the efficacy of clomiphene citrate-metformin combination and clomiphene citrate monotherapy for ovulation induction in infertile patients with normal BMI. Study Design: Randomized controlled trial. Duration and Place of Study: The study was conducted from December 2024 to May 2025 at the Department of Obstetrics and Gynaecology, POF Hospital Wah Cantt. Methodology: A total of 100 infertile women aged 25-35 years with a normal BMI (20–25 kg/m²) were enrolled using non-probability consecutive sampling. Patients were randomized into two groups: Group A (clomiphene citrate 50 mg combined with metformin 1500 mg daily) and Group B (clomiphene citrate 50 mg daily). The primary endpoint was ovulation, assessed by progesterone levels on the 21st day of the menstrual cycle. Results: The combination therapy group (Group A) demonstrated a significantly higher ovulation rate (74%) compared to the monotherapy group (Group B), which showed a 30% success rate (p<0.01). Stratified analysis revealed superior outcomes in younger patients (≤30 years), those with a BMI ≤23 kg/m², and those with a shorter duration of infertility (≤5 years). Conclusion: Clomiphene citrate-metformin combination therapy is significantly more effective than clomiphene citrate monotherapy for ovulation induction in infertile women, particularly in younger women and those with a normal BMI.
Downloads
References
1. Nik Hazlina NH, Norhayati MN, Shaiful Bahari I, Nik Muhammad Arif NA, Worldwide prevalence, risk factors and psychological impact of infertility among women: a systematic review and meta-analysis. BMJ Open. 2022;12(3):e057132.
https://doi.org/10.1136/bmjopen-2021-057132.
2. Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454.
https://doi.org/10.3390/jcm12041454.
3. Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65-76.
https://doi.org/10.1001/jama.2021.4788.
4. Zhuang S, Jing C, Yu L, Ji L, Liu W, Hu X. The relationship between polycystic ovary syndrome and infertility: a bibliometric analysis. Ann Transl Med. 2022;10(6):318.
https://doi.org/10.21037/atm-22-714.
5. Öztürk R, Herbell K, Morton J, Bloom T. "The worst time of my life": treatment-related stress and unmet needs of women living with infertility. J Community Psychol. 2021;49(5):1121-1133.
https://doi.org/10.1002/jcop.22527.
6. Ren M, Liu J, Zhang Y, Fan L. Effects of different ovulation induction regimens on sex hormone levels and serum CTRP3 and CTRP15 levels in patients with polycystic ovary syndrome (PCOS). Biomed Res Int. 2022;2022:6027878.
https://doi.org/10.1155/2022/6027878.
7. Cunha A, Póvoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed J. 2021;6(1):e116.
https://doi.org/10.1097/j.pbj.0000000000000116.
8. Emokpae MA, Brown SI. Effects of lifestyle factors on fertility: practical recommendations for modification. Reprod Fertil. 2021;2(1):R13-R26.
https://doi.org/10.1530/RAF-20-0046.
9. Jurczewska J, Szostak-Węgierek D. The influence of diet on ovulation disorders in women-a narrative review. Nutrients. 2022;14(8):1556.
https://doi.org/10.3390/nu14081556.
10. Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679.
https://doi.org/10.1093/humrep/dead156.
11. Wasim T, Nasrin T, Zunair J, Irshad S. Efficacy of letrozole vs clomiphene citrate for induction of ovulation in women with polycystic ovarian syndrome. Pak J Med Sci. 2024;40(1Part-I):78-83.
https://doi.org/10.12669/pjms.40.1.7971.
12. Elkhalifa WS, Suliman HM, Abdoon IH, Mohamed W, Osman B. Letrozole vs clomiphene citrate in Sudanese patients with infertility secondary to polycystic ovary syndrome. Heliyon. 2023;9(7):e18107.
https://doi.org/10.1016/j.heliyon.2023.e18107.
13. Saadati S, Mason T, Godini R, Vanky E, Teede H, Mousa A. Metformin use in women with polycystic ovary syndrome (PCOS): opportunities, benefits, and clinical challenges. Diabetes Obes Metab. 2025;27(Suppl 3):31-47.
https://doi.org/10.1111/dom.16422.
14. Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:741764.
https://doi.org/10.3389/fendo.2021.741764.
15. Herman R, Kravos NA, Jensterle M, Janež A, Dolžan V. Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport. Int J Mol Sci. 2022;23(3):1264.
https://doi.org/10.3390/ijms23031264.
16. Peng G, Yan Z, Liu Y, Li J, Ma J, Tong N, et al. The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis. Reprod Biol Endocrinol. 2023;21(1):24.
https://doi.org/10.1186/s12958-023-01075-9.
17. Gul HM, Ather S, Ain QU. Comparison of efficacy of clomiphene citrate alone and with glucophage for treatment of infertility in polycystic ovarian syndrome. J Soc Obstet Gynaecol Pak. 2022;12(3):272-5.
18. Arvindar T. A comparative study of different treatment modalities of polycystic ovarian syndrome in women of reproductive age group at tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2023;12(9):2785-92.
https://doi.org/10.18203/2320-1770.ijrcog20232739
19. Palomba S, Falbo A, La Sala GB. Ovulation induction in anovulatory patients with polycystic ovary syndrome. South Asian Fed Obstet and Gynecol. 2010;2(3):175-82.
https://doi.org/10.5005/jp-journals-10006-1092
20. Kamenov Z, Kolarov G, Gateva A, Carlomagno G, Genazzani AD. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol. 2015;31(2):131-5.
https://doi.org/10.3109/09513590.2014.964640
21. Basirat Z, Adib Rad H, Esmailzadeh S, Jorsaraei SG, Hajian-Tilaki K, Pasha H, et al. Enhanced ovarian follicular development by metformin does not correlate with pregnancy rate: a randomized trial. Int J Fertil Steril. 2012;6(1):31-6.
https://doi.org/10.29252/ijrm.14.1.39
22. El Gohary DS, Allam AA, Elsaid NY. Effect of empagliflozin metformin with clomiphene citrate versus metformin with clomiphene citrate on cases of polycystic ovary syndrome. J Med Sci Res. 2023;6(2):10-4.
https://doi.org/10.59299/2537-0928.1025
23. Vaidya T, Mahajan N, Rathod K, Patel S. Comparison of clomiphene citrate versus clomiphene citrate and metformin combination in ovulation induction for subfertile women with polycystic ovarian syndrome. World J Pharm Res. 2018;7(3):858-71.
24. Abuelghar WM, Khairy MM, Elsayed HH, Abdelaziz A. Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomized controlled trial. Middle East Fertil Soc J. 2013;18(3):135-41.
https://doi.org/10.1016/j.mefs.2013.05.002
25. Patel H, Rupareliya C, Thakur M, Shah JS. The efficacy and safety of clomiphene citrate and metformin on ovulation induction in patients suffering from anovulatory infertility. Int J Basic Clin Pharmacol. 2015;4(6):1241-6.
https://doi.org/10.18203/2319-2003.ijbcp20151366
26. Sadiq F, Bhatti A, Zahra N, Khan A. Comparison between the efficacy of metformin plus clomiphene and clomiphene alone in the treatment of primary infertility due to polycystic ovarian syndrome in obese women. Prof Med J. 2022;29(8):1127-31.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
